CMS Implements New Competitive Rules for Organ Procurement

Procurement organizations now face expanded competition for service areas and stricter tracking requirements.

Updated on Oct. 30, 2026 in Nursing Jobs

Bold flat-color editorial illustration of a sterile medical transport canister, representing organ procurement oversight and regulatory policy.
CMS finalized new rules allowing high-performing organ procurement organizations to expand service areas to help address the national transplant waiting list. AI Illustration. Upload story photo >

Live Poll

Should the government increase oversight of organ procurement organizations to improve transplant access?

CMS finalized a new rule to increase accountability and oversight for Organ Procurement Organizations across the U.S. The policy allows high-performing organizations to compete for additional service areas while mandating stricter tracking for research-bound organs.

Why it matters

The change aims to close the gap between the 100,000 Americans currently on transplant waiting lists and the supply of viable organs. By incentivizing higher performance among procurement organizations, the government is moving to drive continued growth in annual transplant volumes.

Nationwide transplant volume has risen 30% and organ donations have increased 36% since the 2020 CMS performance rule. Currently, more than 100,000 Americans are waiting for transplants, following a record 49,000 procedures performed in 2025.

The players

CMS

The federal agency that administers Medicare and Medicaid and sets quality and performance standards for healthcare providers.

Organ Procurement Organizations

Non-profit entities responsible for the recovery and coordination of organ donations within designated service areas.

The details

The rule introduces a competitive framework allowing high-performing Organ Procurement Organizations (OPOs) to expand their reach into multiple service areas. Incoming organizations must now submit detailed transition plans to ensure operational continuity during these shifts. Additionally, the mandate requires medical directors to hold a valid license in at least one served jurisdiction and tightens reporting standards for organs sent for research, specifically excluding research-only pancreata from performance metrics.

Timeline

  1. 2019: President Trump issued an Executive Order focused on kidney health.

  2. 2020: CMS implemented the original OPO performance measures.

  3. 2025: The U.S. surpassed 49,000 total annual transplants.

  4. October 30, 2026: CMS finalized the new OPO oversight rule.

Market Landscape

This policy follows a pattern established by the 2020 CMS OPO rule by further refining performance accountability. It represents a systematic effort to scale operational efficiency by fostering competition among organ recovery agencies.

Operators in the transplant supply chain should prepare for a more competitive environment regarding service area coverage. Organizations must update tracking protocols for organs diverted to research to remain in compliance with the new CMS reporting requirements.

The takeaway

The government is aggressively shifting toward a competitive model for organ procurement to address the backlog of 100,000 patients. Healthcare facilities should monitor which OPOs are active in their regions to ensure supply chain stability under the new competitive mandates.

Further reading

For context on the broader staffing and care environment, see our coverage of Nursing Jobs.

More information

Review the final rule in federal register for specific reporting requirements.

Live Poll

Should the government increase oversight of organ procurement organizations to improve transplant access?